HOME Research Insight Product Launches and Partnerships—Major Growth Strategies Adopted by Key Players in the Urology Devices Market



Product Launches and Partnerships—Major Growth Strategies Adopted by Key Players in the Urology Devices Market


The urology devices market is expected to reach USD 44.37 Billion by 2022 from USD 31.44 Billion in 2017, at a CAGR of 7.1%. Factors driving the growth of this market include the rising incidence of urological cancer, growing healthcare expenditure, increasing geriatric population, and technological advancements in urology devices

The urology devices market is consolidated in nature due to the presence of a large number of players. The key players in the market are Fresenius Medical Care (Germany), Baxter (US), Boston Scientific (US), Olympus (Japan), Richard Wolf (US), KARL STORZ (Germany), Cook Medical (US), Medtronic (US), C. R. Bard (US), Dornier MedTech (Germany), Prometheus Group (US), Medi-Globe (US), Intuitive Surgical (US), Merit Medical Systems (US), Siemens Healthcare (Germany), Stryker (US), ROCAMED (France), Medica (Italy), NOVAmedtek (Turkey), SRS Medical Systems (US), ProSurg (US), Albyn Medical (UK), EMD Medical Technologies (Canada), and biolitec (Germany).

The key strategies followed by most companies in the urology devcies market are product launches and partnerships. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2017. Some of the leading players who adopted this strategy include Fresenius Medical Care (Germany), Olympus (Japan), Richard Wolf (US), and KARL STORZ (Germany).

In 2016, Medtronic accounted for the largest share of the urology devices market. The company has a wide range of products, covering all major technologies urology devices. Medtronic differentiates its products via branding. The company focuses on growing organically by leveraging its high operating margin. In 2017, Medtronic launched InterStim(TM) system, a neuromodulation therapy which offers improvements for the overactive bladder. 

In 2016, Fresenius Medical Care accounted for the second-largest market share of the urology devices market. The company has a broad product portfolio and has launched innovative products to enable the rapid and accurate diagnosis of urology disorders. The company primarily focuses on developing technologically advanced dialysis products for the treatment of kidney diseases to strengthen its position in this market. This is evident from its recent launches of innovative dialysis products. In 2017, the company launched 6008 CARE systems for the treatment of patients with end-stage renal disease (ESRD).

Related Reports:

Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports